UNIVERSAL BIOSENSORS INC.
ASX: UBI (UNI BIOSEN CDI 1:1 [UBI])
Last update: 17 hours ago0.100
0.00 (1.01%)
Previous Close | 0.099 |
Open | 0.100 |
Volume | 5,000 |
Avg. Volume (3M) | 125,460 |
Market Cap | 29,806,702 |
Price / Sales | 3.87 |
Price / Book | 1.57 |
52 Weeks Range | |
Earnings Date | 29 Jan 2025 - 3 Feb 2025 |
Profit Margin | -175.04% |
Operating Margin (TTM) | -214.84% |
Diluted EPS (TTM) | -0.050 |
Quarterly Revenue Growth (YOY) | -2.50% |
Total Debt/Equity (MRQ) | 16.18% |
Current Ratio (MRQ) | 5.03 |
Operating Cash Flow (TTM) | -14.06 M |
Levered Free Cash Flow (TTM) | -13.11 M |
Return on Assets (TTM) | -32.72% |
Return on Equity (TTM) | -58.81% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (AU) | Mixed | Mixed |
Medical Devices (Global) | Mixed | Mixed | |
Stock | UNI BIOSEN CDI 1:1 [UBI] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -2.5 |
Average | -0.50 |
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Growth |
% Held by Insiders | 10.19% |
% Held by Institutions | 42.77% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |